These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7554259)

  • 21. [Use of a GnRH analogue in the treatment of certain forms of endometrial hyperplasia associated with menometrorrhagia].
    Bonfirraro G; Sanna B; De Marco A; Chieffi O; Bonfirraro PP; Orlando V
    Minerva Ginecol; 1995 Oct; 47(10):467-70. PubMed ID: 8559438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasonography-based triage for perimenopausal patients with abnormal uterine bleeding.
    Goldstein SR; Zeltser I; Horan CK; Snyder JR; Schwartz LB
    Am J Obstet Gynecol; 1997 Jul; 177(1):102-8. PubMed ID: 9240591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disorders.
    Perry CM; Brogden RN
    Drugs; 1996 Feb; 51(2):319-46. PubMed ID: 8808170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zoladex (goserelin acetate) and the anemic patient: results of a multicenter fibroid study.
    Benagiano G; Kivinen ST; Fadini R; Cronjé H; Klintorp S; van der Spuy ZM
    Fertil Steril; 1996 Aug; 66(2):223-9. PubMed ID: 8690106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Goserelin Acetate as Adjunctive Therapy for Endometrial Ablation in Women with Dysfunctional Uterine Bleeding.
    Vilos GA; Donnez J; Gannon M; Stampe-Sorensen S; Klinte J; Miller RM
    J Am Assoc Gynecol Laparosc; 1996 Aug; 3(4, Supplement):S54-5. PubMed ID: 9074262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Add-back therapy for long-term use in dysfunctional uterine bleeding and uterine fibroids.
    Thomas EJ
    Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():18-21. PubMed ID: 8916983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current and future medical treatments for menometrorrhagia during the premenopause.
    Bouchard P
    Gynecol Endocrinol; 2011 Dec; 27 Suppl 1():1120-5. PubMed ID: 22182055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects on bone mineral density of 12-month goserelin treatment in over 40-year-old women with uterine myomas.
    Bianchi S; Fedele L; Vignali M; Galbiati E; Cherubini R; Ortolani S
    Calcif Tissue Int; 1995 Jul; 57(1):78-80. PubMed ID: 7671171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The medical management of abnormal uterine bleeding in reproductive-aged women.
    Bradley LD; Gueye NA
    Am J Obstet Gynecol; 2016 Jan; 214(1):31-44. PubMed ID: 26254516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.
    Dahiya P; Dalal M; Yadav A; Dahiya K; Jain S; Silan V
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():147-51. PubMed ID: 27285306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
    Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
    Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized comparison of goserelin versus suction curettage prior to Thermachoice II balloon endometrial ablation: one-year results.
    Vilos GA; Vilos AG; Abu-Rafea B
    J Obstet Gynaecol Can; 2010 Oct; 32(10):973-9. PubMed ID: 21176307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, placebo-controlled, dose-ranging trial comparing fulvestrant with goserelin in premenopausal patients with uterine fibroids awaiting hysterectomy.
    Donnez J; Hervais Vivancos B; Kudela M; Audebert A; Jadoul P
    Fertil Steril; 2003 Jun; 79(6):1380-9. PubMed ID: 12798886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cost effectiveness analysis of goserelin compared with danazol as endometrial thinning agents.
    Sculpher M; Thompson E; Brown J; Garry R
    BJOG; 2000 Mar; 107(3):340-6. PubMed ID: 10740330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect on menstrual blood loss in women with uterine fibroids of a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E
    Eur J Obstet Gynecol Reprod Biol; 2002 Apr; 102(1):74-9. PubMed ID: 12039094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal uterine bleeding: medical treatment with vaginal danazol and five-year follow-up.
    Mais V; Cossu E; Angioni S; Piras B; Floris L; Melis GB
    J Am Assoc Gynecol Laparosc; 2004 Aug; 11(3):340-3. PubMed ID: 15559345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of goserelin-depot in the clinical management of uterine fibroids.
    Cagnacci A; Paoletti AM; Soldani R; Angiolucci M; Arangino S; Falqui A; Melis GB
    Clin Exp Obstet Gynecol; 1994; 21(4):263-5. PubMed ID: 7994879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometrial thickness screening in premenopausal women with abnormal uterine bleeding.
    Getpook C; Wattanakumtornkul S
    J Obstet Gynaecol Res; 2006 Dec; 32(6):588-92. PubMed ID: 17100821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hysteroscopic ablation of the endometrium in cases of dysfunctional uterine bleeding--advantage of preparations including zoladex].
    Tiufekchieva E; Nikolov A
    Akush Ginekol (Sofiia); 2002; 41(2):30-4. PubMed ID: 12066549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The relationship between simple and atypical endometrial hyperplasia and endometrial carcinoma].
    Borisov I; Maĭnkhard K; Tsankova M
    Akush Ginekol (Sofiia); 1996; 35(4):18-20. PubMed ID: 9254559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.